The industrial Park Confucius is planned to localize in SEZ Technopolis Moscow with the participation of the Pilot zone of the Shanghai cooperation Organization (SCO) in Qingdao and investment firms from the United States

Within the framework of the Boao Asian health forum, an agreement was signed with the participation of SEZ Technopolis Moscow (Russia), the SCO economic development Zone (China), ATEM Healthcare Partners (USA) and The Pharma Partners (China), providing a set of measures for the development of economic cooperation, including the possibility of creating an international hi-tech Park Confucius in Moscow. In addition, the parties create a direct investment Fund, which will be attended by partners from China, the United States and Russia. Confucius hi-tech Park will specialize in industrial issues related to biotechnology, pharmaceuticals, medical equipment and related information technologies. In addition, it is planned to create a large center of traditional Chinese medicine, whose services will be available to residents of Moscow.

The parties agreed to hold a Russian-Chinese investment conference starting in 2019, which will bring together the interests of investors from Russia, China and the United States in the field of technology transfer, intellectual property rights, development of drug production and high-tech products of related industries.

"Representatives of industry and technology platforms from China are frequent guests of SEZ Technopolis Moscow and fruitful cooperation has been established with them to exchange experience in the development of high technologies. I am sure that the placement of Chinese companies in the SEZ will contribute to the development of the industrial potential of the city", — said Alexander Prokhorov, the head of the Department of investment and industrial policy of Moscow.

"We consider the signing of this agreement an important milestone in the further development of trade and economic cooperation between Russia and China, — said Mikhail Getman, Chairman of the biopharmaceutical cluster of SEZ Technopolis Moscow. — The location of the Confucius hi-tech Park on the territory of SEZ Technopolis Moscow will open up new opportunities not only for the biomedical industries of Moscow, but also for all residents of our city. The name of the Park was chosen not by chance, but because of the heritage of the great Chinese philosopher Confucius is directly related to Shandong province, where the city of Qingdao is located”.

"In 2018, the President of China, Jinping XI and the President of Russia Vladimir Putin approved the city of Qingdao as the site for the creation of a pilot zone for the development of trade-economic cooperation of the States members of SCO, says Mr. Hao Guoxin, Deputy head of Zone for economic cooperation. — In our territory, the area of which exceeds 90 square kilometers, there are already residents from Russia. We welcome new partners and strive to develop cooperation with Technopolis Moscow, which is the engine of technological development of the Russian capital. We hope that the parties will make joint efforts to ensure bilateral investment and commercial cooperation between Moscow and Qingdao through this project."

"Russia and China are global technology leaders, and we see great potential in the mutual transfer of biomedical technologies, as well as in production and market cooperation within the framework of the national Chinese initiative "One belt – One road", — said Anton Gopka, co-founder of ATEM Healthcare Partners. — We also welcome the formation of the technology transfer investment Fund to Finance the project activities. The Fund will be able to consolidate innovations in biotechnology, medical technology and digital medicine from around the world and will contribute to the localization and commercialization of the best products in the markets of Russia/CIS and China”.

"We have been implementing cross-border medical projects with China for more than 30 years and have extensive experience in organizing and holding major international conferences of investors, developers and manufacturers, as well as in managing international cooperation projects, — says Tony Chu Tao, founder and head of The Pharma Partners. — Both Russian and Chinese companies can give a lot to each other and benefit from it. We expect high performance of the annual Russian-Chinese investment conference, which will be joined by interested companies and public authorities of the cities of China and Russia. In addition, we hope that companies from Russia and China will be located in the technology parks of Moscow and Qingdao, and we will provide them with all the necessary support in the interests of the peoples of both countries”.

SEZ Technopolis Moscow is a specialized territory for the development of industrial and technical implementation activities of the capital. Currently, 180 high-tech companies are located on the territory of the SEZ, 59 of them are residents and receive a number of preferences from the city: tax benefits, ready engineering infrastructure, free customs zone, etc. Residents of the SEZ are engaged in development and innovation in the field of high-tech production, including microelectronics, instrumentation, information and telecommunication technologies, medical equipment. To date, residents have already invested in the development of their production facilities in the amount of about 23.4 billion rubles and created more than 5,500 jobs.

The transfer of authority to manage SEZ Technopolis Moscow to the Government of the capital took place on September 7, 2016. Since then, 30 new companies have been added to the register of residents. To date, the total amount of declared investments of 30 new residents is 27.5 billion rubles. At the same time, as a result of the projects, more than 5,400 new jobs will be created. Special economic zone is supervised by the Department of investment and industrial policy of Moscow.

The SCO economic development zone in Qingdao is a pilot project that was personally approved by Chinese President XI Jinping and supported by the Chinese Ministry of trade. The project is an innovative model of domestic and international industrial cooperation. The demonstration site is located in the zone of development of air, sea and railway transport. Based on its geographical advantages, Qingdao plays a key role in the creation of the Eurasian belt and Road corridor.

ATEM Healthcare Partners (USA) is an investment company specializing in international investments in the field of biotechnology and medical equipment, as well as the organization of serial technology transfer to Russia, China and other countries. ATEM Healthcare Partners (USA) will be responsible for the establishment and management of the Russia-China Foundation.

TPP Healthcare (China) is a reliable international partner in the Chinese pharmaceutical market, the organizer of the Phoenix Valley Hangzhou Technopark. TPP Healthcare network of contacts includes more than 1000 Chinese pharmaceutical and insurance companies, funds, distributors, pharmacy chains and medical institutions. TPP Healthcare supports the creation of long-term partnerships to develop China's fast-growing medical market.